{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:34:42Z","timestamp":1790224482058,"version":"4.1.0"},"reference-count":154,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T00:00:00Z","timestamp":1707350400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["109\\u20132314-B-038-021-MY3"],"award-info":[{"award-number":["109\\u20132314-B-038-021-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 112\\u20132823\\u20138-038-001"],"award-info":[{"award-number":["NSTC 112\\u20132823\\u20138-038-001"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 111\\u20132622-B-038-008"],"award-info":[{"award-number":["NSTC 111\\u20132622-B-038-008"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 112\\u20132314-B-038-081"],"award-info":[{"award-number":["NSTC 112\\u20132314-B-038-081"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004700","name":"Taipei Medical University","doi-asserted-by":"publisher","award":["TMU108-AE1-B12"],"award-info":[{"award-number":["TMU108-AE1-B12"]}],"id":[{"id":"10.13039\/501100004700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.bbcan.2024.189085","type":"journal-article","created":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T11:41:08Z","timestamp":1707392468000},"page":"189085","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["PBX1 as a novel master regulator in cancer: Its regulation, molecular biology, and therapeutic applications"],"prefix":"10.1016","volume":"1879","author":[{"given":"Ting-Wan","family":"Kao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiao-Han","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao-An","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.bbcan.2024.189085_bb0005","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1111\/jcmm.17196","article-title":"The regulation of PBXs and their emerging role in cancer","volume":"26","author":"Liu","year":"2022","journal-title":"J. Cell. Mol. Med."},{"issue":"4","key":"10.1016\/j.bbcan.2024.189085_bb0010","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/0092-8674(90)90658-2","article-title":"A new homeobox gene contributes the DNA binding domain of the t(1;19) translocation protein in pre-B ALL","volume":"60","author":"Kamps","year":"1990","journal-title":"Cell."},{"issue":"4","key":"10.1016\/j.bbcan.2024.189085_bb0015","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/0092-8674(90)90657-Z","article-title":"Chromosomal translocation t(1;19) results in synthesis of a homeobox fusion mRNA that codes for a potential chimeric transcription factor","volume":"60","author":"Nourse","year":"1990","journal-title":"Cell."},{"issue":"3","key":"10.1016\/j.bbcan.2024.189085_bb0020","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1101\/gad.5.3.358","article-title":"The human t(1;19) translocation in pre-B ALL produces multiple nuclear E2A-Pbx1 fusion proteins with differing transforming potentials","volume":"5","author":"Kamps","year":"1991","journal-title":"Genes Dev."},{"issue":"9","key":"10.1016\/j.bbcan.2024.189085_bb0025","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1002\/humu.24388","article-title":"The TALE never ends: a comprehensive overview of the role of PBX1, a TALE transcription factor, in human developmental defects","volume":"43","author":"Mary","year":"2022","journal-title":"Hum. Mutat."},{"issue":"18","key":"10.1016\/j.bbcan.2024.189085_bb0030","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1242\/dev.128.18.3543","article-title":"Requirement for Pbx1 in skeletal patterning and programming chondrocyte proliferation and differentiation","volume":"128","author":"Selleri","year":"2001","journal-title":"Development."},{"issue":"12","key":"10.1016\/j.bbcan.2024.189085_bb0035","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1007\/s00109-021-02139-2","article-title":"PBX1: a key character of the hallmarks of cancer","volume":"99","author":"Veiga","year":"2021","journal-title":"J. Mol. Med. (Berl.)"},{"issue":"13","key":"10.1016\/j.bbcan.2024.189085_bb0040","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1182\/blood.2021014391","article-title":"Systems medicine dissection of chr1q-amp reveals a novel PBX1-FOXM1 axis for targeted therapy in multiple myeloma","volume":"139","author":"Trasanidis","year":"2022","journal-title":"Blood."},{"key":"10.1016\/j.bbcan.2024.189085_bb0045","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3389\/fcell.2017.00009","article-title":"PBX1 as Pioneer factor: a case still open","volume":"5","author":"Grebbin","year":"2017","journal-title":"Front. Cell Dev. Biol."},{"issue":"11","key":"10.1016\/j.bbcan.2024.189085_bb0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1002368","article-title":"PBX1 genomic pioneer function drives ER\u03b1 signaling underlying progression in breast cancer","volume":"7","author":"Magnani","year":"2011","journal-title":"PLoS Genet."},{"issue":"5","key":"10.1016\/j.bbcan.2024.189085_bb0055","doi-asserted-by":"crossref","DOI":"10.1002\/bies.201600245","article-title":"A tale of TALE, PREP1, PBX1, and MEIS1: interconnections and competition in cancer","volume":"39","author":"Blasi","year":"2017","journal-title":"Bioessays."},{"key":"10.1016\/j.bbcan.2024.189085_bb0060","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3389\/fendo.2018.00346","article-title":"Prep1, a homeodomain transcription factor involved in glucose and lipid metabolism","volume":"9","author":"Oriente","year":"2018","journal-title":"Front. Endocrinol. (Lausanne)."},{"issue":"34","key":"10.1016\/j.bbcan.2024.189085_bb0065","doi-asserted-by":"crossref","first-page":"26172","DOI":"10.1074\/jbc.M001323200","article-title":"Functional cloning and characterization of a novel nonhomeodomain protein that inhibits the binding of PBX1-HOX complexes to DNA","volume":"275","author":"Abramovich","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bbcan.2024.189085_bb0070","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/dvdy.24016","article-title":"Biochemistry of the tale transcription factors PREP, MEIS, and PBX in vertebrates","volume":"243","author":"Longobardi","year":"2014","journal-title":"Dev. Dyn."},{"issue":"1","key":"10.1016\/j.bbcan.2024.189085_bb0075","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0014-4827(03)00262-3","article-title":"Myb-binding protein 1a is a nucleocytoplasmic shuttling protein that utilizes CRM1-dependent and independent nuclear export pathways","volume":"289","author":"Keough","year":"2003","journal-title":"Exp. Cell Res."},{"issue":"1","key":"10.1016\/j.bbcan.2024.189085_bb0080","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/emboj\/cdg010","article-title":"PBX1 nuclear export is regulated independently of PBX-MEINOX interaction by PKA phosphorylation of the PBC-B domain","volume":"22","author":"Kilstrup-Nielsen","year":"2003","journal-title":"EMBO J."},{"issue":"16","key":"10.1016\/j.bbcan.2024.189085_bb0085","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1101\/gad.1103303","article-title":"Structure of HoxA9 and Pbx1 bound to DNA: Hox hexapeptide and DNA recognition anterior to posterior","volume":"17","author":"LaRonde-LeBlanc","year":"2003","journal-title":"Genes Dev."},{"issue":"21","key":"10.1016\/j.bbcan.2024.189085_bb0090","doi-asserted-by":"crossref","first-page":"8852","DOI":"10.1158\/0008-5472.CAN-08-0517","article-title":"Identification of Pbx1, a potential oncogene, as a Notch3 target gene in ovarian cancer","volume":"68","author":"Park","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2024.189085_bb0095","doi-asserted-by":"crossref","first-page":"4286213","DOI":"10.1155\/2019\/4286213","article-title":"NANOG attenuates hair follicle-derived mesenchymal stem cell senescence by upregulating PBX1 and activating AKT signaling","volume":"2019","author":"Liu","year":"2019","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"1","key":"10.1016\/j.bbcan.2024.189085_bb0100","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/jcb.20057","article-title":"Retinoic acid regulates the expression of PBX1, PBX2, and PBX3 in P19 cells both transcriptionally and post-translationally","volume":"92","author":"Qin","year":"2004","journal-title":"J. Cell. Biochem."},{"issue":"21","key":"10.1016\/j.bbcan.2024.189085_bb0105","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232112741","article-title":"Targeting SPHK1\/PBX1 Axis induced cell cycle arrest in non-small cell lung Cancer","volume":"23","author":"Lin","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.bbcan.2024.189085_bb0110","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1002\/pros.20443","article-title":"PLZF regulates Pbx1 transcription and Pbx1-HoxC8 complex leads to androgen-independent prostate cancer proliferation","volume":"66","author":"Kikugawa","year":"2006","journal-title":"Prostate."},{"issue":"4","key":"10.1016\/j.bbcan.2024.189085_bb0115","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/cac2.12281","article-title":"M(6) A-mediated regulation of PBX1-GCH1 axis promotes gastric cancer proliferation and metastasis by elevating tetrahydrobiopterin levels","volume":"42","author":"Liu","year":"2022","journal-title":"Cancer Commun. (Lond)."},{"issue":"2","key":"10.1016\/j.bbcan.2024.189085_bb0120","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/s41388-019-0998-9","article-title":"Oncogenic heterogeneous nuclear ribonucleoprotein D-like modulates the growth and imatinib response of human chronic myeloid leukemia CD34(+) cells via pre-B-cell leukemia homeobox 1","volume":"39","author":"Ji","year":"2020","journal-title":"Oncogene."},{"key":"10.1016\/j.bbcan.2024.189085_bb0125","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ceb.2018.02.011","article-title":"Post-transcriptional regulation of gene expression and human disease","volume":"52","author":"Corbett","year":"2018","journal-title":"Curr. Opin. Cell Biol."},{"issue":"12","key":"10.1016\/j.bbcan.2024.189085_bb0130","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22126199","article-title":"Identification of tumor suppressive genes regulated by miR-31-5p and miR-31-3p in head and neck squamous cell carcinoma","volume":"22","author":"Oshima","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.bbcan.2024.189085_bb0135","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23042277","article-title":"Interplay between ceRNA and epigenetic control of microRNA: modelling approaches with application to the role of estrogen in ovarian Cancer","volume":"23","author":"Huang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"21","key":"10.1016\/j.bbcan.2024.189085_bb0140","doi-asserted-by":"crossref","first-page":"5901","DOI":"10.1158\/1078-0432.CCR-12-3776","article-title":"A tumorigenic factor interactome connected through tumor suppressor microRNA-198 in human pancreatic cancer","volume":"19","author":"Marin-Muller","year":"2013","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.bbcan.2024.189085_bb0145","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3892\/etm.2021.11020","article-title":"MicroRNA-141-3p inhibits the progression of oral squamous cell carcinoma via targeting PBX1 through the JAK2\/STAT3 pathway","volume":"23","author":"Cao","year":"2022","journal-title":"Exp. Ther. Med."},{"issue":"11","key":"10.1016\/j.bbcan.2024.189085_bb0150","doi-asserted-by":"crossref","first-page":"7405","DOI":"10.1007\/s11033-021-06756-5","article-title":"rs6426881 in the 3\u2019-UTR of PBX1 is involved in breast and gastric cancers via altering the binding potential of miR-522-3p","volume":"48","author":"Mohammadi","year":"2021","journal-title":"Mol. Biol. Rep."},{"issue":"5","key":"10.1016\/j.bbcan.2024.189085_bb0155","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.21037\/tcr.2020.04.19","article-title":"RGMB-AS1\/miR-4428\/PBX1 axis drives the progression of cervical cancer","volume":"9","author":"Shen","year":"2020","journal-title":"Transl. Cancer Res."},{"issue":"12","key":"10.1016\/j.bbcan.2024.189085_bb0160","first-page":"2438","article-title":"Uc.38 induces breast cancer cell apoptosis via PBX1","volume":"7","author":"Zhang","year":"2017","journal-title":"Am. J. Cancer Res."},{"issue":"8","key":"10.1016\/j.bbcan.2024.189085_bb0165","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1007\/s11626-018-0284-0","article-title":"LncRNA-uc.40 silence promotes P19 embryonic cells differentiation to cardiomyocyte via the PBX1 gene","volume":"54","author":"Wu","year":"2018","journal-title":"In Vitro Cell. Dev. Biol. Anim."},{"issue":"12","key":"10.1016\/j.bbcan.2024.189085_bb0170","doi-asserted-by":"crossref","first-page":"4572","DOI":"10.1074\/jbc.RA118.006057","article-title":"Inhibition of the deubiquitinase USP9x induces pre-B cell homeobox 1 (PBX1) degradation and thereby stimulates prostate cancer cell apoptosis","volume":"294","author":"Liu","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2024.189085_bb0175","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.9952","article-title":"Master regulator genes and their impact on major diseases","volume":"8","author":"Cai","year":"2020","journal-title":"PeerJ."},{"issue":"36","key":"10.1016\/j.bbcan.2024.189085_bb0180","doi-asserted-by":"crossref","first-page":"E3775","DOI":"10.1073\/pnas.1407074111","article-title":"Transcription factor PREP1 induces EMT and metastasis by controlling the TGF-\u03b2-SMAD3 pathway in non-small cell lung adenocarcinoma","volume":"111","author":"Risolino","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"9","key":"10.1016\/j.bbcan.2024.189085_bb0185","doi-asserted-by":"crossref","first-page":"757","DOI":"10.2174\/1568009622666220413084456","article-title":"PBX1 participates in estrogen-mediated bladder Cancer progression and chemo-resistance affecting estrogen receptors","volume":"22","author":"Zhao","year":"2022","journal-title":"Curr. Cancer Drug Targets"},{"issue":"2\u20134","key":"10.1016\/j.bbcan.2024.189085_bb0190","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1159\/000324790","article-title":"Epigenetic regulation of early osteogenesis and mineralized tissue formation by a HOXA10-PBX1-associated complex","volume":"194","author":"Gordon","year":"2011","journal-title":"Cells Tissues Organs"},{"issue":"5","key":"10.1016\/j.bbcan.2024.189085_bb0195","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1007\/s13277-013-0864-2","article-title":"Overexpression of response gene to complement 32 (RGC32) promotes cell invasion and induces epithelial-mesenchymal transition in lung cancer cells via the NF-\u03baB signaling pathway","volume":"34","author":"Sun","year":"2013","journal-title":"Tumour Biol.\u202f: J. Int. Soc. Oncodevelopm. Bio. Med."},{"issue":"2","key":"10.1016\/j.bbcan.2024.189085_bb0200","first-page":"973","article-title":"Inhibition of cell proliferation and migration in non-small cell lung cancer cells through the suppression of LYPLA1","volume":"41","author":"Mohammed","year":"2019","journal-title":"Oncol. Rep."},{"issue":"5","key":"10.1016\/j.bbcan.2024.189085_bb0205","first-page":"573","article-title":"Inhibition of non-small-cell lung cancer cell proliferation by Pbx1","volume":"26","author":"Li","year":"2014","journal-title":"Chin. J. Cancer Res. = Chung-kuo yen cheng yen chiu"},{"issue":"4","key":"10.1016\/j.bbcan.2024.189085_bb0210","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/ncb1709","article-title":"Functional interaction between FOXO3a and ATM regulates DNA damage response","volume":"10","author":"Tsai","year":"2008","journal-title":"Nat. Cell Biol."},{"issue":"12","key":"10.1016\/j.bbcan.2024.189085_bb0215","doi-asserted-by":"crossref","first-page":"4359","DOI":"10.1111\/cas.14659","article-title":"Upregulation of S100A10 in metastasized breast cancer stem cells","volume":"111","author":"Yanagi","year":"2020","journal-title":"Cancer Sci."},{"issue":"11","key":"10.1016\/j.bbcan.2024.189085_bb0220","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1002\/ijc.30680","article-title":"Overexpression of lipid metabolism genes and PBX1 in the contralateral breasts of women with estrogen receptor-negative breast cancer","volume":"140","author":"Wang","year":"2017","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2024.189085_bb0225","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.canlet.2021.07.027","article-title":"HPIP protooncogene differentially regulates metabolic adaptation and cell fate in breast cancer cells under glucose stress via AMPK and RNF2 dependent pathways","volume":"518","author":"Penugurti","year":"2021","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.bbcan.2024.189085_bb0230","first-page":"26","article-title":"Emerging role of pioneer transcription factors in targeted ER\u03b1 positive breast cancer","volume":"2","author":"Pavithran","year":"2021","journal-title":"Explorat. Target. Anti-Tumor Therap."},{"issue":"16","key":"10.1016\/j.bbcan.2024.189085_bb0235","doi-asserted-by":"crossref","first-page":"E1490","DOI":"10.1073\/pnas.1219992110","article-title":"Genome-wide reprogramming of the chromatin landscape underlies endocrine therapy resistance in breast cancer","volume":"110","author":"Magnani","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"8","key":"10.1016\/j.bbcan.2024.189085_bb0240","first-page":"1642","article-title":"FoxC1 promotes epithelial-mesenchymal transition through PBX1 dependent transactivation of ZEB2 in esophageal cancer","volume":"7","author":"Zhu","year":"2017","journal-title":"Am. J. Cancer Res."},{"issue":"4","key":"10.1016\/j.bbcan.2024.189085_bb0245","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1007\/s12253-020-00803-5","article-title":"PBX1 increases the Radiosensitivity of Oesophageal squamous Cancer by targeting of STAT3","volume":"26","author":"Yu","year":"2020","journal-title":"Pathol. Oncol. Res.\u202f: POR."},{"issue":"29","key":"10.1016\/j.bbcan.2024.189085_bb0250","doi-asserted-by":"crossref","first-page":"46818","DOI":"10.18632\/oncotarget.17473","article-title":"A hydrophobic residue in the TALE homeodomain of PBX1 promotes epithelial-to-mesenchymal transition of gastric carcinoma","volume":"8","author":"He","year":"2017","journal-title":"Oncotarget."},{"issue":"2","key":"10.1016\/j.bbcan.2024.189085_bb0255","doi-asserted-by":"crossref","first-page":"262","DOI":"10.4149\/neo_2020_200806N823","article-title":"Upregulation of microRNA-650 by PBX1 is correlated with the development of helicobacter pylori-associated gastric carcinoma","volume":"68","author":"Liu","year":"2021","journal-title":"Neoplasma."},{"issue":"18","key":"10.1016\/j.bbcan.2024.189085_bb0260","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.7150\/jca.31829","article-title":"BolA family member 2 enhances cell proliferation and predicts a poor prognosis in hepatocellular carcinoma with tumor hemorrhage","volume":"10","author":"Luo","year":"2019","journal-title":"J. Cancer"},{"issue":"12","key":"10.1016\/j.bbcan.2024.189085_bb0265","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.prp.2014.07.011","article-title":"A low level of GPR37 is associated with human hepatocellular carcinoma progression and poor patient survival","volume":"210","author":"Liu","year":"2014","journal-title":"Pathol. Res. Pract."},{"issue":"4","key":"10.1016\/j.bbcan.2024.189085_bb0270","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.3892\/ijo.2017.4111","article-title":"SERP1 is a novel marker of poor prognosis in pancreatic ductal adenocarcinoma patients via anti-apoptosis and regulating SRPRB\/NF-\u03baB axis","volume":"51","author":"Ma","year":"2017","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbcan.2024.189085_bb0275","doi-asserted-by":"crossref","first-page":"699","DOI":"10.2147\/OTT.S284211","article-title":"CPNE1 enhances colorectal Cancer cell growth, glycolysis, and drug resistance through regulating the AKT-GLUT1\/HK2 pathway","volume":"14","author":"Wang","year":"2021","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.bbcan.2024.189085_bb0280","doi-asserted-by":"crossref","first-page":"11971","DOI":"10.1038\/ncomms11971","article-title":"Oncogenic PIK3CA mutations reprogram glutamine metabolism in colorectal cancer","volume":"7","author":"Hao","year":"2016","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.bbcan.2024.189085_bb0285","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.bbrc.2018.04.127","article-title":"PBX1 promotes the cell proliferation via JAK2\/STAT3 signaling in clear cell renal carcinoma","volume":"500","author":"Wei","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"9","key":"10.1016\/j.bbcan.2024.189085_bb0290","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.24606","article-title":"An insight into the diagnostic and prognostic value of HOX A13\u2019s expression in non-muscle invasive bladder cancer","volume":"36","author":"Setti Boubaker","year":"2022","journal-title":"J. Clin. Lab. Anal."},{"issue":"17","key":"10.1016\/j.bbcan.2024.189085_bb0295","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.121497","article-title":"Targeting CD46 for both adenocarcinoma and neuroendocrine prostate cancer","volume":"3","author":"Su","year":"2018","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.bbcan.2024.189085_bb0300","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41418-019-0339-0","article-title":"JOSD1 inhibits mitochondrial apoptotic signalling to drive acquired chemoresistance in gynaecological cancer by stabilizing MCL1","volume":"27","author":"Wu","year":"2020","journal-title":"Cell Death Differ."},{"issue":"5","key":"10.1016\/j.bbcan.2024.189085_bb0305","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0036054","article-title":"Identification of PBX1 target genes in cancer cells by global mapping of PBX1 binding sites","volume":"7","author":"Thiaville","year":"2012","journal-title":"PLoS One"},{"issue":"6c","key":"10.1016\/j.bbcan.2024.189085_bb0310","first-page":"4943","article-title":"CD46 expression is indicative of shorter revival-free survival for ovarian cancer patients","volume":"26","author":"Surowiak","year":"2006","journal-title":"Anticancer Res."},{"issue":"11","key":"10.1016\/j.bbcan.2024.189085_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.103297","article-title":"Development of small molecule inhibitors targeting PBX1 transcription signaling as a novel cancer therapeutic strategy","volume":"24","author":"Shen","year":"2021","journal-title":"iScience."},{"issue":"5","key":"10.1016\/j.bbcan.2024.189085_bb0320","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13050980","article-title":"Short-form Thymic stromal Lymphopoietin (sfTSLP) is the predominant isoform expressed by Gynaecologic cancers and promotes tumour growth","volume":"13","author":"Chan","year":"2021","journal-title":"Cancers."},{"issue":"15","key":"10.1016\/j.bbcan.2024.189085_bb0325","doi-asserted-by":"crossref","first-page":"6561","DOI":"10.7150\/thno.44868","article-title":"FABP5 promotes lymph node metastasis in cervical cancer by reprogramming fatty acid metabolism","volume":"10","author":"Zhang","year":"2020","journal-title":"Theranostics."},{"issue":"1","key":"10.1016\/j.bbcan.2024.189085_bb0330","doi-asserted-by":"crossref","first-page":"22420","DOI":"10.1038\/s41598-022-27107-9","article-title":"CD46 protects the bladder cancer cells from cetuximab-mediated cytotoxicity","volume":"12","author":"Do","year":"2022","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.bbcan.2024.189085_bb0335","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1158\/1541-7786.MCR-10-0334","article-title":"TROY (TNFRSF19) is overexpressed in advanced glial tumors and promotes glioblastoma cell invasion via Pyk2-Rac1 signaling","volume":"8","author":"Paulino","year":"2010","journal-title":"Mol. Cancer Res.\u202f: MCR."},{"issue":"8","key":"10.1016\/j.bbcan.2024.189085_bb0340","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1158\/1541-7786.MCR-13-0008","article-title":"TROY (TNFRSF19) promotes glioblastoma survival signaling and therapeutic resistance","volume":"11","author":"Loftus","year":"2013","journal-title":"Mol. Cancer Res.\u202f: MCR."},{"issue":"3","key":"10.1016\/j.bbcan.2024.189085_bb0345","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/sj.onc.1209800","article-title":"Pre-B-cell leukemia transcription factor 1 is a major target of promyelocytic leukemia zinc-finger-mediated melanoma cell growth suppression","volume":"26","author":"Shiraishi","year":"2007","journal-title":"Oncogene."},{"issue":"1","key":"10.1016\/j.bbcan.2024.189085_bb0350","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41392-022-01222-5","article-title":"G-quadruplexes folding mediates downregulation of PBX1 expression in melanoma","volume":"8","author":"Sui","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"4","key":"10.1016\/j.bbcan.2024.189085_bb0355","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060208","article-title":"The role of hnRPUL1 involved in DNA damage response is related to PARP1","volume":"8","author":"Hong","year":"2013","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.bbcan.2024.189085_bb0360","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.7150\/ijbs.33881","article-title":"FZD2 regulates cell proliferation and invasion in tongue squamous cell carcinoma","volume":"15","author":"Huang","year":"2019","journal-title":"Int. J. Biol. Sci."},{"issue":"3","key":"10.1016\/j.bbcan.2024.189085_bb0365","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/leu.2012.265","article-title":"GCN5 acetylates and regulates the stability of the oncoprotein E2A-PBX1 in acute lymphoblastic leukemia","volume":"27","author":"Holmlund","year":"2013","journal-title":"Leukemia."},{"issue":"7350","key":"10.1016\/j.bbcan.2024.189085_bb0370","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/nature10107","article-title":"A somitic Wnt16\/notch pathway specifies haematopoietic stem cells","volume":"474","author":"Clements","year":"2011","journal-title":"Nature."},{"issue":"1","key":"10.1016\/j.bbcan.2024.189085_bb0375","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/1756-9966-30-112","article-title":"MEIS1, PREP1, and PBX4 are differentially expressed in acute lymphoblastic leukemia: association of MEIS1 expression with higher proliferation and chemotherapy resistance","volume":"30","author":"Rosales-Avi\u00f1a","year":"2011","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.bbcan.2024.189085_bb0380","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1128\/MCB.21.1.224-234.2001","article-title":"Defining roles for HOX and MEIS1 genes in induction of acute myeloid leukemia","volume":"21","author":"Thorsteinsdottir","year":"2001","journal-title":"Mol. Cell. Biol."},{"issue":"10","key":"10.1016\/j.bbcan.2024.189085_bb0385","doi-asserted-by":"crossref","first-page":"5434","DOI":"10.1128\/MCB.15.10.5434","article-title":"Meis1, a PBX1-related homeobox gene involved in myeloid leukemia in BXH-2 mice","volume":"15","author":"Moskow","year":"1995","journal-title":"Mol. Cell. Biol."},{"issue":"18","key":"10.1016\/j.bbcan.2024.189085_bb0390","doi-asserted-by":"crossref","first-page":"9617","DOI":"10.1074\/jbc.M115.701979","article-title":"The ring finger protein RNF6 induces leukemia cell proliferation as a direct target of pre-B-cell leukemia Homeobox 1","volume":"291","author":"Xu","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2024.189085_bb0395","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.945038","article-title":"Whole-exome sequencing and bioinformatics analysis of a case of non-alpha-fetoprotein-elevated lung hepatoid adenocarcinoma","volume":"13","author":"Yao","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"26","key":"10.1016\/j.bbcan.2024.189085_bb0400","doi-asserted-by":"crossref","first-page":"21878","DOI":"10.18632\/oncotarget.4243","article-title":"The pioneer factor PBX1 is a novel driver of metastatic progression in ER\u03b1-positive breast cancer","volume":"6","author":"Magnani","year":"2015","journal-title":"Oncotarget."},{"issue":"11","key":"10.1016\/j.bbcan.2024.189085_bb0405","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.1128\/MCB.02055-05","article-title":"Deletion of SERP1\/RAMP4, a component of the endoplasmic reticulum (ER) translocation sites, leads to ER stress","volume":"26","author":"Hori","year":"2006","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbcan.2024.189085_bb0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104511","article-title":"Targeting glucose metabolism to suppress cancer progression: prospective of anti-glycolytic cancer therapy","volume":"150","author":"Abdel-Wahab","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bbcan.2024.189085_bb0415","first-page":"159","article-title":"The role of membrane complement regulatory proteins in cancer immunotherapy","volume":"632","author":"Yan","year":"2008","journal-title":"Adv. Exp. Med. Biol."},{"issue":"6","key":"10.1016\/j.bbcan.2024.189085_bb0420","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0038842","article-title":"ZEB2 mediates multiple pathways regulating cell proliferation, migration, invasion, and apoptosis in glioma","volume":"7","author":"Qi","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbcan.2024.189085_bb0425","doi-asserted-by":"crossref","first-page":"10475","DOI":"10.1038\/srep10475","article-title":"Arginine methylation of hnRNPUL1 regulates interaction with NBS1 and recruitment to sites of DNA damage","volume":"5","author":"Gurunathan","year":"2015","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bbcan.2024.189085_bb0430","first-page":"389","article-title":"The American Society of Hematology education program book","volume":"2012","author":"Mullighan","year":"2012","journal-title":"Mol. Genet. Makeup Acute Lymphoblast. Leuk."},{"issue":"1","key":"10.1016\/j.bbcan.2024.189085_bb0435","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.29299","article-title":"Poor prognosis of B-cell acute lymphoblastic leukemia with TCF\/PBX1 fusion gene and ovarian involvement at diagnosis: two case reports and review of the literature","volume":"69","author":"Vinti","year":"2022","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.bbcan.2024.189085_bb0440","article-title":"The advances of E2A-PBX1 fusion in B-cell acute lymphoblastic Leukaemia","author":"Yang","year":"2023","journal-title":"Ann. Hematol."},{"issue":"9","key":"10.1016\/j.bbcan.2024.189085_bb0445","article-title":"The expression pattern of the pre-B cell receptor components correlates with cellular stage and clinical outcome in acute lymphoblastic leukemia","volume":"11","author":"Chen","year":"2016","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.bbcan.2024.189085_bb0450","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S1097-2765(03)00277-6","article-title":"Bmi-1 regulation of INK4A-ARF is a downstream requirement for transformation of hematopoietic progenitors by E2a-Pbx1","volume":"12","author":"Smith","year":"2003","journal-title":"Mol. Cell"},{"issue":"4","key":"10.1016\/j.bbcan.2024.189085_bb0455","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.celrep.2018.03.124","article-title":"SETDB2 links E2A-PBX1 to cell-cycle dysregulation in acute leukemia through CDKN2C repression","volume":"23","author":"Lin","year":"2018","journal-title":"Cell Rep."},{"issue":"11","key":"10.1016\/j.bbcan.2024.189085_bb0460","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1038\/s41417-022-00491-0","article-title":"Functional characterization of the PI3K\/AKT\/MTOR signaling pathway for targeted therapy in B-precursor acute lymphoblastic leukemia","volume":"29","author":"Gr\u00fcninger","year":"2022","journal-title":"Cancer Gene Ther."},{"issue":"6","key":"10.1016\/j.bbcan.2024.189085_bb0465","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1922864118","article-title":"Mediator subunit MED1 is required for E2A-PBX1-mediated oncogenic transcription and leukemic cell growth","volume":"118","author":"Lee","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"9","key":"10.1016\/j.bbcan.2024.189085_bb0470","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1172\/JCI81158","article-title":"Comparative genomics reveals multistep pathogenesis of E2A-PBX1 acute lymphoblastic leukemia","volume":"125","author":"Duque-Afonso","year":"2015","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.bbcan.2024.189085_bb0475","doi-asserted-by":"crossref","DOI":"10.3390\/jdb9040044","article-title":"MEIS1 in hematopoiesis and Cancer. How MEIS1-PBX interaction can be used in therapy","volume":"9","author":"Blasi","year":"2021","journal-title":"J. Dev. Biol."},{"key":"10.1016\/j.bbcan.2024.189085_bb0480","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/1756-9966-30-112","article-title":"MEIS1, PREP1, and PBX4 are differentially expressed in acute lymphoblastic leukemia: association of MEIS1 expression with higher proliferation and chemotherapy resistance","volume":"30","author":"Rosales-Avi\u00f1a","year":"2011","journal-title":"J. Exp. Clin. Cancer Res. [Internet]."},{"issue":"6","key":"10.1016\/j.bbcan.2024.189085_bb0485","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.tig.2016.03.004","article-title":"To be specific or not: the critical relationship between Hox and TALE proteins","volume":"32","author":"Merabet","year":"2016","journal-title":"Trends Genet."},{"issue":"1","key":"10.1016\/j.bbcan.2024.189085_bb0490","doi-asserted-by":"crossref","first-page":"5664","DOI":"10.1038\/s41598-019-42096-y","article-title":"The human HOXA9 protein uses paralog-specific residues of the homeodomain to interact with TALE-class cofactors","volume":"9","author":"Dard","year":"2019","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.bbcan.2024.189085_bb0495","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1242\/dev.00948","article-title":"Prep1.1 has essential genetic functions in hindbrain development and cranial neural crest cell differentiation","volume":"vol. 131","author":"Deflorian","year":"2004","journal-title":"Development (Cambridge, England)"},{"issue":"8","key":"10.1016\/j.bbcan.2024.189085_bb0500","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41408-020-00348-5","article-title":"Cytogenetic abnormalities in multiple myeloma: association with disease characteristics and treatment response","volume":"10","author":"Abdallah","year":"2020","journal-title":"Blood Cancer J."},{"issue":"16","key":"10.1016\/j.bbcan.2024.189085_bb0505","doi-asserted-by":"crossref","first-page":"21353","DOI":"10.18632\/oncotarget.7241","article-title":"Molecular spectrum of TP53 mutations in plasma cell dyscrasias by next generation sequencing: an Italian cohort study and overview of the literature","volume":"7","author":"Lionetti","year":"2016","journal-title":"Oncotarget."},{"issue":"29","key":"10.1016\/j.bbcan.2024.189085_bb0510","doi-asserted-by":"crossref","first-page":"7296","DOI":"10.1200\/JCO.2005.01.3870","article-title":"Molecular classification of multiple myeloma: a distinct transcriptional profile characterizes patients expressing CCND1 and negative for 14q32 translocations","volume":"23","author":"Agnelli","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.bbcan.2024.189085_bb0515","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3892\/etm.2020.8705","article-title":"PBX1 is a valuable prognostic biomarker for patients with breast cancer","volume":"20","author":"Ao","year":"2020","journal-title":"Exp. Ther. Med."},{"issue":"21","key":"10.1016\/j.bbcan.2024.189085_bb0520","doi-asserted-by":"crossref","first-page":"6351","DOI":"10.1158\/0008-5472.CAN-16-0980","article-title":"Ovarian Cancer Chemoresistance relies on the stem cell reprogramming factor PBX1","volume":"76","author":"Jung","year":"2016","journal-title":"Cancer Res."},{"issue":"50","key":"10.1016\/j.bbcan.2024.189085_bb0525","doi-asserted-by":"crossref","first-page":"E11711","DOI":"10.1073\/pnas.1814397115","article-title":"Transcriptional landscape of B cell precursor acute lymphoblastic leukemia based on an international study of 1,223 cases","volume":"115","author":"Li","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"26","key":"10.1016\/j.bbcan.2024.189085_bb0530","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1056\/NEJMoa0900386","article-title":"Treating childhood acute lymphoblastic leukemia without cranial irradiation","volume":"360","author":"Pui","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.bbcan.2024.189085_bb0535","doi-asserted-by":"crossref","DOI":"10.1016\/j.currproblcancer.2021.100758","article-title":"Clinical features and prognostic impact of TCF3-PBX1 in childhood acute lymphoblastic leukemia: a single-center retrospective study of 837 patients from China","volume":"45","author":"Jia","year":"2021","journal-title":"Curr. Probl. Cancer"},{"issue":"8","key":"10.1016\/j.bbcan.2024.189085_bb0540","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1038\/leu.2009.42","article-title":"Increased risk for CNS relapse in pre-B cell leukemia with the t(1;19)\/TCF3-PBX1","volume":"23","author":"Jeha","year":"2009","journal-title":"Leukemia."},{"issue":"4","key":"10.1016\/j.bbcan.2024.189085_bb0545","doi-asserted-by":"crossref","first-page":"e136","DOI":"10.3324\/haematol.2016.152926","article-title":"The central nervous system microenvironment influences the leukemia transcriptome and enhances leukemia chemo-resistance","volume":"102","author":"Gaynes","year":"2017","journal-title":"Haematologica."},{"issue":"16","key":"10.1016\/j.bbcan.2024.189085_bb0550","doi-asserted-by":"crossref","first-page":"4400","DOI":"10.1158\/1078-0432.CCR-13-1486","article-title":"PBX1 is a favorable prognostic biomarker as it modulates 13-cis retinoic acid-mediated differentiation in neuroblastoma","volume":"20","author":"Shah","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2024.189085_bb0555","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.3389\/fonc.2019.01221","article-title":"Comparative analysis of putative prognostic and predictive markers in neuroblastomas: high expression of PBX1 is associated with a poor response to induction therapy","volume":"9","author":"Veselska","year":"2019","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.bbcan.2024.189085_bb0560","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0218269","article-title":"Prediction of neuroblastoma cell response to treatment with natural or synthetic retinoids using selected protein biomarkers","volume":"14","author":"Dobrotkova","year":"2019","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bbcan.2024.189085_bb0565","doi-asserted-by":"crossref","first-page":"8955","DOI":"10.1038\/s41598-022-13148-7","article-title":"PBX1, EMCN and ERG are associated with the sub-clusters and the prognosis of VHL mutant clear cell renal cell carcinoma","volume":"12","author":"Wang","year":"2022","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.bbcan.2024.189085_bb0570","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1016\/j.stemcr.2021.09.016","article-title":"PBX1-directed stem cell transcriptional program drives tumor progression in myeloproliferative neoplasm","volume":"16","author":"Muggeo","year":"2021","journal-title":"Stem Cell Rep."},{"issue":"1","key":"10.1016\/j.bbcan.2024.189085_bb0575","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12929-020-00638-x","article-title":"A novel c-kit\/phospho-prohibitin axis enhances ovarian cancer stemness and chemoresistance via Notch3-PBX1 and \u03b2-catenin-ABCG2 signaling","volume":"27","author":"Fang","year":"2020","journal-title":"J. Biomed. Sci."},{"issue":"10","key":"10.1016\/j.bbcan.2024.189085_bb0580","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2020.100817","article-title":"Ibrutinib is not an effective drug in primografts of TCF3-PBX1","volume":"13","author":"van de Ven","year":"2020","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.bbcan.2024.189085_bb0585","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2019.113638","article-title":"Advances and challenges in studying noncoding RNA regulation of drug metabolism and development of RNA therapeutics","volume":"169","author":"Ning","year":"2019","journal-title":"Biochem. Pharmacol."},{"issue":"8","key":"10.1016\/j.bbcan.2024.189085_bb0590","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/s41573-021-00219-z","article-title":"Noncoding RNA therapeutics - challenges and potential solutions","volume":"20","author":"Winkle","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"issue":"19","key":"10.1016\/j.bbcan.2024.189085_bb0595","doi-asserted-by":"crossref","first-page":"32322","DOI":"10.18632\/oncotarget.15971","article-title":"Targeting HOX\/PBX dimers in cancer","volume":"8","author":"Morgan","year":"2017","journal-title":"Oncotarget."},{"key":"10.1016\/j.bbcan.2024.189085_bb0600","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.semcdb.2018.07.019","article-title":"Modulating transcription factor activity: interfering with protein-protein interaction networks","volume":"99","author":"Francois","year":"2020","journal-title":"Semin. Cell Dev. Biol."},{"issue":"4","key":"10.1016\/j.bbcan.2024.189085_bb0605","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s10456-005-9016-7","article-title":"Pbx1 is required for Hox D3-mediated angiogenesis","volume":"8","author":"Charboneau","year":"2005","journal-title":"Angiogenesis."},{"issue":"5","key":"10.1016\/j.bbcan.2024.189085_bb0610","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/sj.onc.1203371","article-title":"HoxA9-mediated immortalization of myeloid progenitors requires functional interactions with TALE cofactors Pbx and Meis","volume":"19","author":"Schnabel","year":"2000","journal-title":"Oncogene."},{"issue":"7104","key":"10.1016\/j.bbcan.2024.189085_bb0615","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/nature04980","article-title":"Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9","volume":"442","author":"Krivtsov","year":"2006","journal-title":"Nature."},{"issue":"49","key":"10.1016\/j.bbcan.2024.189085_bb0620","doi-asserted-by":"crossref","first-page":"6356","DOI":"10.1038\/onc.2008.233","article-title":"Evidence for Hox and E2A-PBX1 collaboration in mouse T-cell leukemia","volume":"27","author":"Bijl","year":"2008","journal-title":"Oncogene."},{"issue":"7","key":"10.1016\/j.bbcan.2024.189085_bb0625","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.1128\/MCB.15.7.3786","article-title":"Both Pbx1 and E2A-Pbx1 bind the DNA motif ATCAATCAA cooperatively with the products of multiple murine Hox genes, some of which are themselves oncogenes","volume":"15","author":"Lu","year":"1995","journal-title":"Mol. Cell. Biol."},{"issue":"56","key":"10.1016\/j.bbcan.2024.189085_bb0630","doi-asserted-by":"crossref","first-page":"8033","DOI":"10.1038\/sj.onc.1203377","article-title":"An inhibitory switch derepressed by pbx, hox, and Meis\/Prep1 partners regulates DNA-binding by pbx1 and E2a-pbx1 and is dispensable for myeloid immortalization by E2a-pbx1","volume":"18","author":"Calvo","year":"1999","journal-title":"Oncogene."},{"issue":"12","key":"10.1016\/j.bbcan.2024.189085_bb0635","doi-asserted-by":"crossref","first-page":"5806","DOI":"10.1158\/0008-5472.CAN-06-4231","article-title":"Antagonism of HOX\/PBX dimer formation blocks the in vivo proliferation of melanoma","volume":"67","author":"Morgan","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2024.189085_bb0640","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1471-2490-14-17","article-title":"Targeting HOX transcription factors in prostate cancer","volume":"14","author":"Morgan","year":"2014","journal-title":"BMC Urol."},{"issue":"2","key":"10.1016\/j.bbcan.2024.189085_bb0645","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s10549-012-2259-2","article-title":"Targeting the HOX\/PBX dimer in breast cancer","volume":"136","author":"Morgan","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"issue":"3","key":"10.1016\/j.bbcan.2024.189085_bb0650","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/sj.bjc.6604857","article-title":"HOX transcription factors are potential therapeutic targets in non-small-cell lung cancer (targeting HOX genes in lung cancer)","volume":"100","author":"Plowright","year":"2009","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbcan.2024.189085_bb0655","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s12885-016-2106-7","article-title":"HOX transcription factors are potential targets and markers in malignant mesothelioma","volume":"16","author":"Morgan","year":"2016","journal-title":"BMC Cancer"},{"issue":"7","key":"10.1016\/j.bbcan.2024.189085_bb0660","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1002\/ijc.30204","article-title":"The prognostic significance of specific HOX gene expression patterns in ovarian cancer","volume":"139","author":"Kelly","year":"2016","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2024.189085_bb0665","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/1471-2407-10-89","article-title":"Targeting HOX and PBX transcription factors in ovarian cancer","volume":"10","author":"Morgan","year":"2010","journal-title":"BMC Cancer"},{"issue":"5","key":"10.1016\/j.bbcan.2024.189085_bb0670","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1111\/cas.13993","article-title":"Targeting HOX\/PBX dimer formation as a potential therapeutic option in esophageal squamous cell carcinoma","volume":"110","author":"Shen","year":"2019","journal-title":"Cancer Sci."},{"issue":"1","key":"10.1016\/j.bbcan.2024.189085_bb0675","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1186\/s12885-022-09466-8","article-title":"HOX and PBX gene dysregulation as a therapeutic target in glioblastoma multiforme","volume":"22","author":"Arunachalam","year":"2022","journal-title":"BMC Cancer"},{"issue":"5","key":"10.1016\/j.bbcan.2024.189085_bb0680","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1016\/j.juro.2008.07.018","article-title":"Disrupting the interaction between HOX and PBX causes necrotic and apoptotic cell death in the renal cancer lines CaKi-2 and 769-P","volume":"180","author":"Shears","year":"2008","journal-title":"J. Urol."},{"key":"10.1016\/j.bbcan.2024.189085_bb0685","series-title":"Profiling and Targeting HOX-PBX Dimers in Adult and Paediatric Glioblastoma as a Novel Therapy","author":"Rogers","year":"2017"},{"issue":"1","key":"10.1016\/j.bbcan.2024.189085_bb0690","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00280-013-2316-5","article-title":"Peptide-based inhibition of the HOXA9\/PBX interaction retards the growth of human meningioma","volume":"73","author":"Ando","year":"2014","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"1","key":"10.1016\/j.bbcan.2024.189085_bb0695","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1186\/s12885-018-4622-0","article-title":"Targeting HOX-PBX interactions causes death in oral potentially malignant and squamous carcinoma cells but not normal oral keratinocytes","volume":"18","author":"Platais","year":"2018","journal-title":"BMC Cancer"},{"issue":"52","key":"10.1016\/j.bbcan.2024.189085_bb0700","doi-asserted-by":"crossref","first-page":"89566","DOI":"10.18632\/oncotarget.20023","article-title":"Inhibition of HOX\/PBX dimer formation leads to necroptosis in acute myeloid leukemia cells","volume":"8","author":"Alharbi","year":"2017","journal-title":"Oncotarget."},{"issue":"11","key":"10.1016\/j.bbcan.2024.189085_bb0705","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22115670","article-title":"A computer-based methodology to design non-standard peptides potentially able to prevent HOX-PBX1-associated Cancer diseases","volume":"22","author":"Gulotta","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2024.189085_bb0710","series-title":"Evaluating the Efficacy of HTL001, a Cell Penetrating Peptide that Targets the HOX\/PBX Interaction in Ovarian cancer","author":"Falgari","year":"2020"},{"issue":"4","key":"10.1016\/j.bbcan.2024.189085_bb0715","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/s41416-020-01166-z","article-title":"HOX genes promote cell proliferation and are potential therapeutic targets in adrenocortical tumours","volume":"124","author":"Francis","year":"2021","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.bbcan.2024.189085_bb0720","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/sj.emboj.7600038","article-title":"Hematopoietic, angiogenic and eye defects in Meis1 mutant animals","volume":"23","author":"Hisa","year":"2004","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.bbcan.2024.189085_bb0725","doi-asserted-by":"crossref","first-page":"16809","DOI":"10.1038\/s41598-020-74032-w","article-title":"Mapping the native interaction surfaces of PREP1 with PBX1 by cross-linking mass-spectrometry and mutagenesis","volume":"10","author":"Bruckmann","year":"2020","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.bbcan.2024.189085_bb0730","doi-asserted-by":"crossref","first-page":"E896","DOI":"10.1073\/pnas.1321200111","article-title":"Prep1 and Meis1 competition for Pbx1 binding regulates protein stability and tumorigenesis","volume":"111","author":"Dardaei","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"21","key":"10.1016\/j.bbcan.2024.189085_bb0735","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1101\/gad.1602107","article-title":"Meis1 is an essential and rate-limiting regulator of MLL leukemia stem cell potential","volume":"21","author":"Wong","year":"2007","journal-title":"Genes Dev."},{"issue":"8","key":"10.1016\/j.bbcan.2024.189085_bb0740","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/nrc.2017.36","article-title":"Drugging the \u2018undruggable\u2019 cancer targets","volume":"17","author":"Dang","year":"2017","journal-title":"Nat. Rev. Cancer"},{"issue":"9","key":"10.1016\/j.bbcan.2024.189085_bb0745","article-title":"Genetic features of B-cell lymphoblastic lymphoma with TCF3-PBX1","volume":"5","author":"Shirai","year":"2022","journal-title":"Cancer Rep. (Hoboken)."},{"issue":"2","key":"10.1016\/j.bbcan.2024.189085_bb0750","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0087602","article-title":"Direct and indirect targets of the E2A-PBX1 leukemia-specific fusion protein","volume":"9","author":"Diakos","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bbcan.2024.189085_bb0755","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1039\/c2ib20114c","article-title":"Rational design of an immunoconjugate for selective knock-down of leukemia-specific E2A-PBX1 fusion gene expression in human pre-B leukemia","volume":"5","author":"Uckun","year":"2013","journal-title":"Integr. Biol. (Camb)."},{"issue":"1","key":"10.1016\/j.bbcan.2024.189085_bb0760","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/leu.2016.202","article-title":"Idelalisib sensitivity and mechanisms of disease progression in relapsed TCF3-PBX1 acute lymphoblastic leukemia","volume":"31","author":"Eldfors","year":"2017","journal-title":"Leukemia."},{"issue":"3","key":"10.1016\/j.bbcan.2024.189085_bb0765","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ccell.2015.02.003","article-title":"Self-enforcing feedback activation between BCL6 and pre-B cell receptor signaling defines a distinct subtype of acute lymphoblastic leukemia","volume":"27","author":"Geng","year":"2015","journal-title":"Cancer Cell"},{"issue":"7","key":"10.1016\/j.bbcan.2024.189085_bb0770","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1158\/1078-0432.CCR-14-2034","article-title":"Idelalisib: first-in-class PI3K Delta inhibitor for the treatment of chronic lymphocytic leukemia, small lymphocytic leukemia, and follicular lymphoma","volume":"21","author":"Yang","year":"2015","journal-title":"Clin. Cancer Res."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X24000167?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X24000167?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T13:02:27Z","timestamp":1777554147000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X24000167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":154,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S0304419X24000167"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2024.189085","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PBX1 as a novel master regulator in cancer: Its regulation, molecular biology, and therapeutic applications","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2024.189085","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"189085"}}